Last reviewed · How we verify
NCT04012749
UC Health Care Planning Study
NA trial testing Advance directive in Advance Care Planning in 8,707 participants. Completed in 15 September 2024.
30 June 2022
Quick facts
| Lead sponsor | University of California, Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 8,707 |
| Start date | 25 October 2019 |
| Primary completion | 30 June 2022 |
| Estimated completion | 15 September 2024 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Advance directive
- Prepare
- Facilitator
Conditions studied
- Advance Care Planning — all drugs for Advance Care Planning →
- Advance Directives — all drugs for Advance Directives →
- Advanced Cancer — all drugs for Advanced Cancer →
Sponsor
University of California, Los Angeles
Who can join
18 and older, any sex, with Advance Care Planning or Advance Directives. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using a cluster randomized design at the clinic level, this project will implement and test three real-world, scalable advance care planning interventions among primary care clinics across three University of California health systems. Seriously ill patients identified using data from the electronic health record will receive (1) an advance directive with targeted messaging, (2) intervention 1 plus prompting to engage with the Prepare For Your Care website, or (3) intervention 2 plus engagement from a clinic-based facilitator. A Research cohort of patients will provide complete surveys at baseline, 12 and 24 months. The main outcomes are advance directive completion among the population cohort and goal concordant care among the Research cohort at 12 months.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Support for Use of Consumer Assessment of Healthcare Providers and Systems Communication Items Among Seriously Ill Patients.
Hays RD, Walling AM, Sudore RL, Chau A, et al · · 2023 · cited 4× · PMID 37093298 · DOI 10.1089/jpm.2022.0572 -
Advance Directive Completion Among Community-Dwelling Adults with Decompensated Cirrhosis.
Patel AA, Walling AM, Sudore RL, Tseng CH, et al · · 2025 · cited 1× · PMID 41455037 · DOI 10.1007/s10620-025-09616-5 -
Interventions to Improve Advance Care Planning Documentation in the Electronic Health Record : A Cluster Randomized Trial.
Walling AM, Sudore RL, Gibbs L, Rahimi M, et al · · 2026 · cited 1× · PMID 41285010 · DOI 10.7326/annals-25-02111 -
Standard HIPAA Authorization Forms Decreased Response Rates for a Multi-site Pragmatic Trial.
Walling AM, Wenger NS, Chau AJ, Reihm J, et al · · 2025 · PMID 39438380 · DOI 10.1007/s11606-024-09074-1
Verify or expand the search:
- PubMed search for NCT04012749
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Advance Care Planning
Currently open trials in the same condition.
- NCT07235839 — The Impact of an Advance Care Planning Game on Life-Sustaining Treatment Preferences, Depression, and Hope in Older Adul · NA · active not recruiting
- NCT07134881 — Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE) · NA · recruiting
- NCT06538493 — Jumpstarting Advance Care Planning With ANAI People · NA · recruiting
- NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting
- NCT06376799 — Which Health-care Professional(s) to Talk About Advance Care Planning ? · recruiting
Other University of California, Los Angeles trials
Trials by the same sponsor.
- NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
- NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
- NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04012749 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
- Last refreshed: 13 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04012749.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing